InvestorsHub Logo
Followers 24
Posts 2408
Boards Moderated 0
Alias Born 04/12/2006

Re: None

Monday, 05/11/2020 1:34:32 PM

Monday, May 11, 2020 1:34:32 PM

Post# of 541

On May 5, 2020, Biomerica received a CE mark and launched a new high-volume production version of its COVID-19 IgG/IgM Rapid Test (the “COVID-19 Test”) that utilizes a proprietary card system that eliminates most plastic. The COVID-19 Test is a serology, finger prick blood test designed to detect antibodies in a person to indicate if that person has had an immune response to the novel Corona Virus (SARS CoV-2). In addition, Biomerica expanded its provisional patent applications to include new technology that is being validated to simplify blood sample collection for its high throughput ELISA test.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMRA News